Coagulation Disorder Clinical Trial
Official title:
Evaluation of the Role of Sonoclot Signature in Assessment of Coagulopathy in Critically Ill COVID 19 Patients
| NCT number | NCT04479280 |
| Other study ID # | 17300446 |
| Secondary ID | |
| Status | Completed |
| Phase | |
| First received | |
| Last updated | |
| Start date | July 20, 2020 |
| Est. completion date | August 16, 2020 |
| Verified date | September 2020 |
| Source | Assiut University |
| Contact | n/a |
| Is FDA regulated | No |
| Health authority | |
| Study type | Observational |
Novel coronavirus disease 19 (COVID-19) is caused by severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2), this pneumonia was first emerged in December 2019 in Wuhan, China
and rapidly spread around the world .
Coagulopathy is one of the most significant prognostic factors in patients with COVID-19 and
is associated with increased mortality and admission to critical care. Most observed
coagulopathy in patients hospitalized with COVID-19 (COVID-19-associated coagulopathy) is
characterized by increased D-dimer and fibrinogen levels. 71% of patients who did not survive
hospitalization reported to have developed disseminated intravascular coagulation
| Status | Completed |
| Enrollment | 70 |
| Est. completion date | August 16, 2020 |
| Est. primary completion date | August 16, 2020 |
| Accepts healthy volunteers | No |
| Gender | All |
| Age group | N/A and older |
| Eligibility |
Inclusion Criteria: - COVID 19 critically ill patients Exclusion Criteria: - any critical illness not related to COVID 19 |
| Country | Name | City | State |
|---|---|---|---|
| Egypt | Assiut university | Assiut |
| Lead Sponsor | Collaborator |
|---|---|
| Assiut University |
Egypt,
| Type | Measure | Description | Time frame | Safety issue |
|---|---|---|---|---|
| Primary | clot rate formation | measuring how rapid the sample will get clotted | 30 minutes |
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT03826043 -
THrombo-Embolic Event in Onco-hematology
|
N/A | |
| Recruiting |
NCT04274777 -
The Relationship Between Lipid Peroxidation Products From Traumatic Brain Injury and Secondary Coagulation Disorders
|
||
| Recruiting |
NCT03136510 -
Evolution of Coagulation Activity in Non Valvular Atrial Fibrillation Patients Under Apixaban
|
N/A | |
| Completed |
NCT01588132 -
Anfibatide Phase 1 Clinical Trial in Healthy Volunteers
|
Phase 1 | |
| Recruiting |
NCT04488341 -
Effect of Aerobic Exercises on Sex Hormones and Coagulation Factors in Postmenopausal Elderly Women
|
N/A | |
| Recruiting |
NCT04524637 -
The Utility of Thromboelastography in Traumatic Brain Injury
|
||
| Completed |
NCT03634215 -
Estimation of Coagulation Factor XIII Activity Based on the Initial Plasma Fibrinogen Level in Trauma
|
||
| Completed |
NCT05152420 -
Study of Intravenous VMX-C001 in Healthy Subjects and in Combination With Selected Direct Oral Anticoagulants in Healthy Older Subjects
|
Phase 1 | |
| Recruiting |
NCT05645081 -
Extracellular Vesicles and Dysregulated Coagulation in the Prediction of Stroke
|
||
| Completed |
NCT04322721 -
Coagulopathy on the First Postoperative Day Predicts the Long-term Survival of Traumatic Brain Injury Patients
|
||
| Completed |
NCT03267823 -
INR Comparison Testing in Cardiac Surgery
|
||
| Completed |
NCT04490759 -
QStat Pilot Reference Range Study
|
||
| Completed |
NCT04107818 -
Comparison of Viscoelastic Measurement by ROTEM® Delta and ClotPro® in Trauma Patients.
|
||
| Recruiting |
NCT05484830 -
Coagulation in Acute Aortic Dissection
|
N/A | |
| Recruiting |
NCT04111120 -
Heparin Like Effect in Acute Variceal Bleeding
|
||
| Completed |
NCT05162339 -
Inflammatory Bowel Disease and Thromboembolic Events
|
||
| Completed |
NCT03555630 -
Thromboelastogram in Postdelivery Preeclamptic Patients
|
||
| Completed |
NCT01589172 -
Evaluating the Use of Thromboelastography to Diagnose Coagulopathy After Traumatic Brain Injury
|
||
| Recruiting |
NCT04278404 -
Pharmacokinetics, Pharmacodynamics, and Safety Profile of Understudied Drugs Administered to Children Per Standard of Care (POPS)
|
||
| Completed |
NCT03956836 -
Perioperative Coagulopathy in Patients Undergoing Cytoreductive Surgery and HIPEC Intraperitoneal Chemotherapy (HIPEC)
|